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The diagnosis and treatment of symptomatic chondral lesions in young and active middle-aged patients continues to be a
challengingissue.Surgeonsmustdiﬀerentiatebetweenincidentalchondrallesionsfromsymptomaticpathologythatisresponsible
for the patient’s pain. A thorough history, physical examination, and imaging work up is necessary and often results in a
diagnosis of exclusion that is veriﬁed on arthroscopy. Treatment of symptomatic glenohumeral chondral lesions depends on
several factors including the patient’s age, occupation, comorbidities, activity level, degree of injury and concomitant shoulder
pathology. Furthermore, the size, depth, and location of symptomatic cartilaginous injury should be carefully considered. Patients
with lower functional demands may experience success with nonoperative measures such as injection or anti-inﬂammatory
pharmacotherapy. When conservative management fails, surgical options are broadly classiﬁed into palliative, reparative,
restorative, and reconstructive techniques. Patients with lower functional demands and smaller lesions are best suited for simpler,
lower morbidity palliative procedures such as debridement (chondroplasty) and cartilage reparative techniques (microfracture).
Those with higher functional demands and large glenohumeral defects will usually beneﬁt more from restorative techniques
including autograft or allograft osteochondral transfers and autologous chondrocyte implantation (ACI). Reconstructive surgical
options are best suited for patients with bipolar lesions.
1.Introduction
While the cause of primary glenohumeral osteoarthritis is
largely unknown, secondary osteoarthritis is often due to
trauma, acute or recurrent dislocation, or prior surgery. Pri-
mary glenohumeral arthritis typically results in posterior
glenoid wear with posterior humeral head subluxation oc-
curring in up to 50% of aﬀected shoulders. Rotator cuﬀ tears
occur in less than 5–10% of cases of primary osteoarthritis.
Joint space narrowing occurs with periarticular osteophyte
formation most commonly on the inferior aspect of the
humeral head. As a result, the anterior soft tissues such as the
capsuleandsubscapularisbecomecontractedandstiﬀ,limit-
ing external rotation [1]. With the growing elderly popula-
tion in the US, the number of total shoulder arthroplasties
performed each year has doubled over the past decade to
approximately 20,000 cases [2]. While glenohumeral osteo-
arthritis typically aﬀects older patients, in some cases it can
aﬀect younger, active patients causing signiﬁcant pain and
disability [3, 4].
The role of glenohumeral chondral lesions in the natural
history of shoulder arthritis has not been well established, as
most cartilaginous lesions of the glenohumeral joint are
found incidentally and are well tolerated in young individ-
uals. The diagnosis and treatment of symptomatic chondral
shoulder lesions in young and active middle-aged patients is
challenging and lacks a clear diagnostic algorithm. Often
times the diagnosis is only reached when all other shoulder
pathologies and causes of glenohumeral pain have been con-
sidered [5]. There are multiple sources of shoulder pain
which must be considered in addition to cartilage lesions in-
cluding labral pathology, biceps tenosynovitis, rotator cuﬀ
pathology, infection, and loose bodies.
Chondral lesions of the glenohumeral joint are not un-
commonandhavebeenfoundincidentallyin4.5–8.5%upto
17% of middle-aged patients with full-thickness rotator cuﬀ2 Advances in Orthopedics
tears during diagnostic arthroscopy [6–8]. Cartilage injuries
may occur on the humeral head, glenoid, or both. These
lesions often result after traumatic injury, arthroscopic sur-
gery, osteochondritis dissecans, infection, chondrolysis, or
avascularnecrosis[9].Mostcommonly,however,lesionsmay
result as an early manifestation of degenerative arthritis.
Chondral lesions have been noted in previous reports rang-
ing from minor cartilage lesions such as fraying or thinning
to complete cartilage loss [7]. One of the main diﬃculties in
managing these chondral lesions is determining if they are a
pain generator as even large lesions can be well tolerated. In
addition, treatment is challenging as shoulder arthroplasty is
not ideal in a younger age group despite its pain relief and
restoration of function.
Initial treatment for symptomatic chondral lesions con-
sists of nonoperative management with activity modiﬁca-
tion, steroid injections, and physical therapy [10]. If these
therapies fail, there are a limited number of surgical options
available. Previous studies have investigated the long-term
outcomes of total shoulder arthroplasty and noted good cli-
nical success, particularly older patient with glenohumeral
degenerative disease and an intact rotator cuﬀ—in one ser-
ies by Torchia et al., pain relief was achieved in 83% and
implant survival was 93% after 10 years [11]. In young and
middle-aged patients, clinical success has been mixed. Sper-
ling et al., in a recent series of 33 patients with a mean age of
46yearsatthetimeofTSA,reporteda38%incidenceofglen-
oid component failure requiring revision surgery [12]. Non-
arthroplasty treatment strategies for glenohumeral arthritis
have been devised in eﬀort to postpone the need for total
shoulder arthroplasty and avoid the incidence of early glen-
oidloosening—thesetechniquesareintegraltothetreatment
of younger patients with painful chondral lesions.
In place of arthroplasty, arthroscopic treatments have
been used including debridement, chondroplasty, capsular
release, biceps tenotomy or tenodesis, and subacromial de-
compression, and more recently reparative techniques inclu-
ding microfracture, autologous chondrocyte implantation,
or osteochondral grafting [13]. However, the outcomes of
these treatments are highly variable in regards to pain relief
and restoration of function. The purpose of this paper is to
examine the evaluation and management of glenohumeral
chondral lesions and discuss the surgical treatment options
for young and middle-aged patients.
2. Methods
A comprehensive Pubmed search was performed using the
following Boolean search terms: glenohumeral arthritis,
glenohumeral osteoarthritis, management, young patients.
The yield of over 80 articles was examined carefully with em-
phasis placed on publications focusing on non-arthroplasty
alternatives.Thesearticlesservedasthebasisforthispaperin
addition to our clinical experience.
3. PatientEvaluation
As noted by Gartsman et al., patients with glenohumeral
arthritis will generally reveal complaints of pain, disability,
and loss of quality of life which may be common to many
types of shoulder pathology [4]. Patient symptoms are often
of nonspeciﬁc shoulder pain and mechanical complaints
[5]. The examiner should elicit a history of glenohumeral
trauma or instability, activities, and arm positions that cause
pain, eﬀusions, neurological complaints, and prior operative
and nonoperative shoulder interventions [14]. The examiner
should have a general understanding of the demand a pa-
tient places upon their shoulder, including their athletic acti-
vities/aspirationsandoccupationaldemands.Ahistoryofin-
stability may be particularly valuable given the connection
between prior subluxation and dislocation events and the
subsequent degeneration of the glenohumeral joint [15].
Generally the diagnosis of a chondral injury is one of exclu-
sion given its relative rarity in comparison to lesions of the
biceps tendon, subacromial space, and capsulo-labroliga-
mentous complex in younger patient cohorts [5, 9]. If prior
surgery has been performed, a review of operative notes and
intraoperative pictures may be helpful in determining the
prior procedures performed and the status of the articular
cartilage at the time of previous arthroscopy.
Examination should include a general shoulder evalua-
tion, with documentation of appearance, tenderness to pal-
pation, range of motion, strength, and neurovascular status.
Capsular contracture with loss of range of motion is com-
mon in cartilage injuries. Pain at full abduction and ﬂexion
issuggestiveofimpingement,whilepainwiththeshoulderin
mid-abduction or mid-ﬂexion is more suggestive of a chon-
dral lesion [5, 9]. Physical exam of the young patient with
a glenohumeral cartilage injury can be complex due to the
variety of possible pain-generating structures within the de-
generative shoulder joint, including the glenoid labrum, the
long head of the biceps tendon (an intra-articular but extra-
synovial structure), the rotator cuﬀ, and the glenoid or hum-
eral articular cartilage [13]. In a degenerated joint, provoca-
tivemaneuversattemptingtoqueryanyofthestructuresmay
be positive. As a result, glenohumeral chondral lesions can
be easily confused with pain secondary to primary patholo-
gies of these structures. In particular, patients with gleno-
humeral arthritis may have similar physical exam ﬁndings to
those with subacromial impingement [8]. Inan eﬀort to diﬀ-
erentiate patients with positive impingement signs between
those with subacromial impingement and those with gleno-
humeral arthritis, Ellman and colleagues (1992) described
the “compression-rotation” test in which the abducted hum-
erus is axially loaded while gently internally and externally
rotating. This test should cause pain in patients with gleno-
humeral arthritis but not those with subacromial impinge-
ment [4, 8]. Injection of the glenohumeral or subacromial
spacewithcongruenteliminationofsymptomsduetopatho-
logy in these respective spaces may be particularly helpful.
Radiographic evaluation of the patient with shoulder
pain should include anteroposterior and lateral views in the
scapular plane with axillary views. Several views have been
developed for speciﬁc evaluation of the glenoid, which may
be progressively deformed in glenohumeral arthritis, includ-
ing the West Point, apical oblique, and Didiee views. The
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chondral injuries, they can be used to grade glenohumeral
arthritis using a system developed by Samilson and Prieto
based upon the size of the glenoid or humeral osteophytes
[16]. Computed tomography, especially with 3D reconstruc-
tion and digital subtraction of the humeral head, oﬀers a
more complete evaluation of the osseous anatomy of the
glenohumeral joint and presence, if any, of glenoid bone loss
[17]. Magnetic resonance imaging (MRI) can best character-
ize the status of the soft tissues, including the rotator cuﬀ
and glenohumeral ligaments. Relative to the knee, a shoulder
MRI is less sensitive for chondral lesions because of the thin
cartilaginous covering in the shoulder [18]. Because these
imaging studies remain imperfect for the diagnosis of chon-
dral injuries in the glenohumeral joint, diagnostic arthro-
scopy remains the gold standard and may be appropriate to
oﬀer in cases of diagnostic uncertainty despite comprehen-
sive noninvasive evaluation and failure of conservative care
[5, 9].
4.SurgicalDecisionMaking
When treating patients with glenohumeral chondral pathol-
ogy,identiﬁcationofpatientswithsymptomatic cartilaginous
lesions and appropriate surgical decision making is para-
mount for success [5]. Cartilage defects are frequently en-
countered on imaging or arthroscopic exam. At the outset, it
is essential to identify those patients whose pain is generated
by these lesions and diﬀerentiate incidental chondral les-
ions from symptomatic ones. Shoulder impingement, com-
monly seen in younger age groups, frequently mimics sym-
ptomatic glenohumeral chondral pathology but is frequently
diﬀerentiated from chondral lesions with the help of the
compression-rotation test [8]. A history of shoulder trauma,
previousshouldersurgery,recurrentsubluxationsordisloca-
tion, mechanical symptoms (catching or clicking), and per-
sistent pain after subacromial diagnostic injection are other
clues that suggest symptomatic chondral pathology [19]. In
our experience, symptomatic chondral lesion should be con-
sidered a diagnosis of exclusion, with all other sources of
shoulder pathology treated ﬁrst, and most reparative proce-
dures should be considered as a secondary option.
Once glenohumeral cartilage pathology is felt to be the
source of pain, a methodical approach should be used for
treatment. Correct surgical or nonsurgical management de-
pends on the patient’s functional demands, co-morbidities,
symptoms, age, occupation, degree of injury, and concomi-
tant shoulder pathology [5]. Furthermore, the size, depth,
and location of symptomatic cartilaginous injury should be
carefullyconsidered.Mostpatientswillhavecartilagepathol-
ogy limited to the glenoid or humeral head (a unipolar le-
sion), but some may have pathologic lesions on both chon-
dral surfaces (bipolar lesions). The presence of bipolar chon-
dral pathology should be prudently noted as surgical treat-
ment options are diﬀe r e n tf r o mt h a tf o ru n i p o l a rl e s i o n s .
Older patients who are poor surgical candidates yet
have symptomatic glenohumeral chondral lesions are well
suited for nonoperative modalities which relieve pain and
maintain shoulder function. Conservative options for treat-
ment include physical therapy, judicious intra-articular ster-
oid injections, and topical or oral nonsteroidal anti-inﬂam-
matory drugs. Glenohumeral viscosupplementation has
s o m e t i m e sb e e nu s e di na no ﬀ-label fashion and may have
a role in providing relief [19–21]. If conservative options fail
in an older age patient with limited shoulder demands, total
shoulder arthroplasty oﬀers the most reproducible long term
outcome with regard to functional improvement and pain
relief. On the other hand, arthroscopic management may be
moreﬁttingforyounger,moreactivepatientswhoarewilling
to comply with postoperative rehabilitation and desire to
maintain high shoulder demand activities [19]. In these
instances, surgical management is broadly classiﬁed into pal-
liative, reparative, restorative, or reconstructive techniques
[5].
A general approach to surgical management of patients
withsymptomatic glenohumeralchondral lesions is outlined
in Figure 1. Patients with lower functional demands and
smaller lesions generally tend to have more success with sim-
pler, low morbidity palliative procedures such as debride-
ment (chondroplasty) and cartilage reparative techniques
(microfracture). Those with higher functional demands and
largeglenohumeralcartilagedefectswillusuallybeneﬁtmore
from cartilage restorative techniques including autograft or
allograft osteochondral transfers and autologous chondro-
cyte implantation (ACI). Reconstructive surgical options are
best suited for patients with bipolar lesions.
5.PalliativeTreatmentStrategies
The mainstay of palliative surgical treatment is arthroscopic
debridement and lavage (chondroplasty). Debridement acts
to alleviate irritating mechanical symptoms that arise from
edge instability. Additionally, arthroscopic debridement sta-
bilizes cartilage lesions, thereby reducing the risk of further
delamination.
The ideal patient for chondroplasty is a low demand, eld-
erly individual (>65 years of age) who presents with a small
chondral defect, typically less than 2cm2 in size [22]. In
performing chondroplasty, a motorized shaver should be
used to gently debride the cartilaginous lesion down to a
stable, vertically oriented rim of cartilage with subchondral
bone at its base. Every attempt should be made to sculpt ver-
tical chondral walls—as shown by Rudd and colleagues,
chondral lesions with vertically oriented walls had signiﬁ-
cantly less defect progression than lesions with walls beveled
at 45 degrees [23]. In addition to debridement, concomitant
shoulder pathologies such as impingement, AC joint arthro-
sis, rotator cuﬀ tears, and biceps or labral pathology should
be addressed simultaneously. In settings of diﬀuse osteoarth-
ritis, chondroplasty may improve shoulder pain by reducing
joint irritation and synovitis and stabilizing the residual arti-
cularsurfacefromfurthercartilagedelamination[19].Inad-
dition, most patients demonstrate restricted range of motion
associated with progressive cartilage degeneration and may
beneﬁt from capsular release and resection of osteophytes.4 Advances in Orthopedics
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Figure 1: Approach to surgical decision making in patients with chondral defects of the glenohumeral joint. Adapted from [5].
Reported results of chondroplasty suggest that the proce-
dure is beneﬁcial in a majority of patients indicated for sur-
gery. In a series of 71 patients undergoing arthroscopic de-
bridement of glenohumeral chondral lesions, Van Thiel et al.
noted signiﬁcant improvement with regards to the American
Shoulder and Elbow Surgeon (ASES) score, simple shoulder
test, and visual analog pain score after surgery [13]. The au-
thors ultimately concluded that arthroscopic debridement of
glenohumeral degenerative joint disease is eﬀective but has
an increased risk of failure in the presence of grade IV bi-
polar disease, joint space less than 2mm, and large osteo-
phytes [13]. Similarly, Cameron et al. found signiﬁcant
improvement with regard to pain and function in 54 out of
61 patients with small, full-thickness chondral defects [22].
6.ReparativeTreatmentStrategies
For well-contained small unipolar cartilage lesions, marrow
stimulation techniques are the next level of treatment that
may be indicated beyond debridement. Microfracture, a
cartilage reparative strategy popularized by Steadman et al.
[24]intheknee,isaﬁrst-linetechniqueforstimulatingﬁbro-
cartilage growth in a chondral defect as a means of providing
structural support to surrounding tissue [5, 9, 24]. The pro-
cedure can be performed arthroscopically in the humerus
or glenoid and does not restrict opportunities for cartilage
restoration in the future. However, diﬀerences in articular
cartilage between the shoulder and knee are signiﬁcant,
which may impact results following microfracture. The
thickness of the articular cartilage in the shoulder is much
thinner than the knee, with maximum thickness of 1.5mm
tapering to less than 1mm at the periphery of the humeral
head and center of the glenoid [11]. In addition, the convex
shape of the humeral head and often peripheral location
of articular defects on the glenoid may limit the ability to
contain the initial clot.
Although the procedure can be performed in a simple
manner, various technical pearls are critical for success. After
identifying the relative boundaries of the chondral defect
using a motorized shaver or curette, the lesion should be
thoroughly debrided to produce vertically oriented walls. By
doing so, the lesion is much better contained and added
stabilityisprovidedtotheneighboringchondraltissue.Next,
the calciﬁed cartilage layer should be thoroughly removed
oﬀ of the subchondral bone using a curette. A sharp awl is
then used to penetrate subchondral bone multiple times as
perpendicularly to the surface as possible—each hole should
beapproximately2-3mmapartandshouldproducebleeding
when the pump is turned oﬀ [19]. It is imperative that
a visual conﬁrmation of subchondral bleeding is noted—
bleeding elements contain various mesenchymal stem cells,
growth factors, and growth proteins that come together
to generate ﬁbrocartilage. Once the procedure is over, a
protected loading and motion protocol should be enacted to
p r o m o t eah e a l i n gr e s p o n s e[ 5].
Although outcomes of microfracture techniques have
mostly been reported in knee literature, various authors
have described their eﬀectiveness in the shoulder (Table 1).
In a case series of 16 patients undergoing microfracture of
glenoid or humeral head chondral defects, Frank et al. noted
signiﬁcant improvement in ASES score, SST score, and visual
analog pain score at a mean followup of 27.8 months [18].
Three of the sixteen patients, however, did ultimately fail the
treatment and went on to further shoulder surgery. Millet
and colleagues examined 25 patients undergoing arthro-
scopic microfracture and also found statistically signiﬁcant
improvements in pain, ASES score, ability to work, activities
of daily living, and sporting activities following surgery
[25]. Interestingly, the authors noted that their best resultsAdvances in Orthopedics 5
Table 1: Outcomes of palliative and reparative treatment for glenohumeral arthritis.
Author Surgical technique Number of patients Main results Other notable ﬁndings
Van Thiel et al. [13] Palliative 71
Signiﬁcant improvement
in pain, SST score, and
range of motion in short
term
22% went on to shoulder
replacement in 10.1
months
Cameron et al. [22] Palliative 61 Signiﬁcant improvement
in pain at 28 months
Workers’ Compensation
patients fared poorly
Weinstein et al. [26] Palliative 25 84% had good or excellent
ﬁndings at 30 months
Poor results associated
with severe joint
incongruity or large
osteophytes
M i l l e t te ta l .[ 25] Reparative 25
Signiﬁcant improvement
in pain, ASES score,
ability to work
Best results in those with
isolated humeral lesions
Frank et al. [18] Reparative 16
Signiﬁcant improvements
in pain, ASES score, and
SST score at 27.8 months
3 patients had failed
results
Snow and Funk [27] Reparative 6 Signiﬁcant improvement
in constant score
Repeat arthroscopy
conﬁrmed good ﬁlling of
lesions with ﬁbrocartilage
occurred in patients with unipolar lesions of the humeral
head [25].
7. Restorative Treatment Strategies
The overall purpose of restorative surgery for glenohumeral
chondral lesions is to anatomically reestablish damaged or
missing cartilage. The primary surgical techniques are osteo-
chondralgraftingusingautograftorallograftandautologous
chondrocyte implantation (ACI). Both of these treatments
necessitate open surgery and have potential complications
such as donor site morbidity and the need for multiple
surgeries (ACI) [5]. Therefore, patient selection is critical to
overall outcomes and patient satisfaction.
The ideal patient for osteochondral grafting or ACI is
young to middle aged, physically active on a regular basis,
with an isolated humeral focal chondral defect. Use of osteo-
chondral autograft has been previously well described for
chondral lesions in the knee but to a much lesser extent in
the shoulder. Scheibel et al. examined a series of eight grade
IV humeral head chondral lesions (average size 150mm2)i n
which he performed osteochondral grafting from the knee
[28]. The authors reported signiﬁcant clinical improvement
in pain and function at 33 months followup. Postoperative
shoulder MRIs showed graft incorporation in all but one
patient, and donor site morbidity from the knee was noted
in two patients. An explanation for donor site morbidity
is that knee contact pressures at osteochondral donor sites
are increased, particularly when taken from the lateral con-
dyle and central trochlea, which limits the amount of cartil-
age available [29]. For deep, extensive, and uncontained gle-
nohumeral chondral lesions, osteochondral grafting using
size-matched allograft from the humeral head or glenoid
remains the best option [5].
Proper size matching is critical when performing osteo-
chondral grafting, and plugs can vary in size, up to 40mm
according to some reports [30]. As outlined by Cole et al.,
there are several general principles that should be followed
when performing osteochondral allografting [5]. The ﬁrst is
appropriate handling and use of fresh cartilage graft tissue.
There is optimal cell viability when fresh grafts are used
within 28 and, ideally, within 21 days of harvest as allografts
have shown a predictable decline in cell viability, cell density,
and metabolic activity with time [31, 32].
Humeral or glenoid size matching is performed using
plain radiographs of the shoulder and size markers to
correct for machine-dependent magniﬁcation. In addition,
a thin shell allograft plug that preserves cartilage integrity
signiﬁcantly decreases the amount of subchondral bone used
andtheantigenicityofthegraft[33].Potentialimmunogenic
responses can further be reduced during the procedure by
using pulsatile lavage of the graft prior to implantation.
Lastly, while press-ﬁt allograft implantation can be achieved,
ﬁxation can be strengthened using bioabsorbable screws or
pins.
Outcome studies of full-thickness cartilage defects of the
knee treated by ACI show good to excellent results at long-
term followup [34]. In regards to the glenohumeral joint,
ACI remains controversial and unproven. There has been a
published case report of a teenage athlete treated with ACI
of the humeral head using a tibial periosteal graft and a two-
stage technique with knee cell growth and shoulder implan-
tation[35].Atoneyearfollowup,thepatienthadnopainand
full range of motion without functional loss.
8.ReconstructiveTreatmentOptions
As opposed to restorative treatment options for smaller,
superﬁcial chondral defects, reconstructive cartilage surgery6 Advances in Orthopedics
may be required for large and deep unipolar or bipolar
defects. Reconstructive surgery is considered a “salvage”
treatment option, with goals of restoring durable function
to the shoulder and decreasing pain, typically as a ﬁnal at-
tempt before considering total shoulder arthroplasty (TSA)
or glenohumeral arthrodesis. While reconstructive surgery
technically includes hemiarthroplasty or TSA, we will focus
on the prearthroplasty management for young and middle
aged patients with signiﬁcant chondral defects. Prearthro-
plasty reconstructive surgery includes resurfacing techniques
tothehumeralheadandglenoid,aswellasbiologicornonbi-
ologic interpositional arthroplasty techniques using a variety
of tissues, such as meniscal allografts, anterior capsule, fascia
lata, Achillestendon allograft, and other specialized matrices.
Suggested potential beneﬁts of biologic glenoid resurfacing
include pain relief and improved range of motion similar to
TSA, without the well-known complications of polyethylene
wear, cement fragmentation, and glenoid loosening or dis-
sociation.
8.1. Resurfacing Arthroplasty. For young and middle-aged
active patients, there is a desire to avoid hemiarthroplasty or
TSA due to high failure rates associated with progressive gle-
noid erosion or glenoid component loosening (∼40%) [12].
Therefore, over the past couple years, attempts to compro-
mise between bone-preserving procedures and arthroplasty
have led to the development of new stemless implants, parti-
cularly in the humerus, which have become promising op-
tions if palliative procedures fail [19]. Similar to resurfacing
proceduresinthehip, however,theuseofresurfacingarthro-
plasty/hemiarthroplasty in the shoulder is controversial.
Stemless implants preserve anatomy and leave open various
options for subsequent revision surgery in the future, but
short- and long-term outcome studies are currently lacking.
In addition, the use of a resurfacing device complicates the
surgical approach to the glenoid limiting options for glenoid
resurfacing or replacement and may result in high rates of
persistent pain or progressive glenoid erosion similar to
tradition hemiarthroplasty.
9.Biologic ResurfacingOptions
Resurfacing arthroplasty using interpositional graft oﬀers
potential advantages over conventional TSA, including the
ability to biologically resurface the glenoid, in addition to
biologic or nonbiologic resurfacing of the humeral head,
thereby avoiding complications of TSA in cases of bipolar
disease.
Several options are available for glenoid resurfacing.
Interpositional grafts may be secured over the glenoid,
thereby oﬀering a biologic surface that articulates with the
humeral head. The use of a lateral meniscus as a biologic
interpositional graft in the glenoid has been described using
bothopenandarthroscopictechniques[36–38].Studieshave
shown that the lateral meniscus provides better glenohum-
eral coverage with reduced peak forces and contact stress
compared to the medial meniscus in the shoulder [39].
Other examples of biological interpositional resurfacing of
the glenoid include Achillestendon allograft, autogenous
fascia lata, anterior shoulder capsule, the Restore patch (De-
Puy Orthopaedics, Warsaw, IN, USA), and the GraftJacket
(donated human skin; Wright Medical Technology, Arling-
ton, TN, USA).
Krishnan and colleagues published a prospective study
analyzing biologic resurfacing of the glenoid using a variety
of interpositional tissues for grafts, including Achillestendon
allograft (18 shoulders), anterior capsule (7 shoulders), and
autogenous fascia lata (11 shoulders) [40]. Their early results
were comparable to results of TSA without the inherent risks
ofarthroplasty,withsigniﬁcantincreasesinmeanASESscor-
es in 31 of 36 patients and no revisions for humeral com-
ponent loosening. They suggested that Achillestendon allo-
graft is the preferred graft type for biologic resurfacing. In
a study of six patients, Burkhead and Hutton performed
porous-coated humeral head hemiarthroplasty along with
glenoid resurfacing using autogenous fascia lata or anterior
shoulder capsule and found good or excellent results in all
patients after two years [36]. Others have reported good re-
sults after arthroscopic glenoid resurfacing using the Restore
patch, an implant made of porcine small intestine submu-
cosal cells with potentially pluripotent properties, with the
hope of regenerating viable chondrocytes and a matrix of
hyaline cartilage on the surface of the glenoid [41]. Finally,
Bhatia described an arthroscopic procedure for resurfacing
the glenoid with the GraftJacket, a regenerative tissue matrix
consisting of processed 1 to 2mm thick human donor skin
that retains native proteins, collagen, and vascular channels
[37].
However, not all authors have reported favorable results
following hemiarthroplasty combined with biologic inter-
position, particularly at longer-term followup. Nicholson
et al. recently published a series of thirty young, high-de-
mand patients with bipolar defects who were treated with
a biologic interpositional lateral meniscus glenoid allograft
anduncementedhemiarthroplasty[42].Theirshort-termre-
sultsoverallweregood,withallpatientsdemonstratingsigni-
ﬁcant improvement in outcome scores after 18 months.
However, they did report a 17% complication rate within the
ﬁrst year, all requiring reoperation, as well as two patients
with graft failure requiring conversion to a polyethylene gle-
noid component [42]. Others have also shown comparable
ﬁndings. Elhassan and colleagues performed a review of 13
patients with an average age of 34 years and average followup
of 48 months undergoing soft-tissue resurfacing of the gle-
noid with a concomitant humeral head arthroplasty. The
authors found that ten of the thirteen patients required a re-
vision total shoulder arthroplasty at a mean of 14 months
postoperatively and concluded that the procedure has poor
outcomes in patients under 50 years [43]. Verma et al. also
noted a high clinical failure rate (51.2%) in 45 patients un-
dergoing biologic resurfacing of the glenoid with lateral
meniscus allograft or human acellular dermal tissue matrix
[44]. An unacceptably high failure ultimately led the authors
torecommendagainsttheprocedure’sutilityinyoung,active
patients with glenohumeral arthritis.
Theseaforementionedtechniquesarecurrentlyinvestiga-
tionalinnatureandmayserveasatemporalbridgeforyoungAdvances in Orthopedics 7
or middle-aged active patients who are not yet candidates for
TSA. Long-term studies demonstrating success and failure
rates are currently lacking, as are randomized, controlled
trials comparing biologic resurfacing techniques with hemi-
arthroplasty, TSA, or other palliative restorative procedures.
10. PostoperativeRehabilitation
The postoperative regimen is important to the success of the
cartilage repair process. With all procedures, early range of
motion is encouraged to increase circulation and promote
healing, but with some limits to protect the repair site. Pa-
tients who have undergone palliative treatment strategies
should begin physical therapy immediately, with range of
motion and strength exercises restricted only by pain. If a
capsular release has also been performed, patients should re-
ceive physical therapy 3 times per week for 6 to 8 weeks.
Patients who had reparative or restorative procedures
should perform 600 cycles of pendulum exercises daily for
the ﬁrst 6 weeks to stimulate the healing response [9]. Active
rangeofmotion exercisescanbe started at6 weeks. However,
animalstudieshavefoundthatﬁbrocartilagemaynotreacha
signiﬁcant degree of maturity until 12 weeks postoperatively,
which suggests that longer periods of protected range of
motion may be beneﬁcial [45].
For reconstructive treatment or any procedures which
require takedown and repair of the subscapularis, a rehabili-
tation protocol similar to that for arthroplasty should be fol-
lowed. No active internal rotation or extension is allowed for
the ﬁrst 6 weeks post-operatively. Passive-to-active range of
motion is gradually advanced to prespeciﬁed limits for exter-
nal rotation (40 degrees), ﬂexion (120 degrees), and abduc-
tion (75 degrees). At 8–12 weeks, range of motion can be
increasedastoleratedandstrengtheningexercisesarestarted.
Patients typically progress to full, unrestricted activities by 6
months, although some cases may take longer to observe the
full beneﬁt.
11. Conclusion
Treatment of glenohumeral cartilage injuries in young pa-
tientscontinuestobeachallengingissue.Surgeonsmustdiﬀ-
erentiate incidental chondral lesions from symptomatic le-
sionsthatareresponsibleforthepatients’pain.Evenwithap-
propriate imaging and a thorough patient history and physi-
cal examination, this remains diﬃcult and often results in
a diagnosis of exclusion that can only be veriﬁed on arthro-
scopy. After identiﬁcation of a symptomatic patient, treat-
ment depends on several factors, including the patient’s age,
comorbidities, degree of injury, concomitant shoulder path-
ology, expectations, and activity level. Patients with lower
functional demands may experience success with nonopera-
tive measures such as medication and injections or arthro-
scopic surgery involving debridement and capsular release.
Young patients with higher functional demands or extensive
arthritismayrequiremoreaggressivesurgicaltreatmentsthat
restore or reconstruct the cartilage. A variety of innov-ative
nonarthroplasty procedures have been utilized for gleno-
humeralarthritisintheyoungpatient,withpromisingshort-
to midterm success. However, long term outcomes or rando-
mized trials are lacking, and future work is required to deter-
mine appropriate indications for each procedure and predic-
tors for lasting success.
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